Biodexa Shares Are Trading Higher After the Company Entered an Exclusive License Agreement With Rapamycin Holdings for the Rights to ERapa
Biodexa與雷帕黴素控股公司簽訂了eRapa權利的獨家許可協議後,該公司股價走高
Biodexa Shares Are Trading Higher After the Company Entered an Exclusive License Agreement With Rapamycin Holdings for the Rights to ERapa
Biodexa與雷帕黴素控股公司簽訂了eRapa權利的獨家許可協議後,該公司股價走高
使用瀏覽器的分享功能,分享給你的好友吧